Oncotelic Therapeutics, Inc. (MATN) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	0.6	0.5	0.1	0.0	1.1	3.5	27.3	30.0
Short-term investments						8.5
Accounts receivable, net	0.0	0.0	0.1
Other current assets	0.0	0.1	0.0		0.0	2.0	0.1	0.3
Total current assets	0.6	0.6	0.3	0.0	1.1	14.1	27.4	30.4
Property, plant, and equipment, net	1.0	1.0	1.4		0.0	0.0	0.0	0.0
Intangibles	0.8	0.9	0.9	1.0
Goodwill	21.1	21.1	21.1
Long-term investments				1.8
Other fixed assets					0.0	0.0	0.0	0.0
Total assets	23.6	23.7	23.7	2.7	1.2	14.1	27.5	30.4

Accounts payable	1.9	1.9	1.8		0.8	0.3	0.3	0.3
Accrued expenses	2.6	2.6	2.6		0.3	0.4	0.3	0.2
Short-term and curr portion of long-term debt [+]	4.0	2.3	0.9	0.0	0.0	0.0	0.0	0.0
Short-term debt		0.3
Current portion of long-term debt	4.0	2.0	0.9
Other current liabilities	6.9	4.3	1.4	0.3	0.6	0.9	1.6	0.9
Total current liabilities	15.5	11.2	6.8	0.3	1.6	1.6	2.1	1.4
Long-term debt	0.7
Total liabilities	16.2	11.2	6.8	0.3	1.6	1.6	2.1	1.4

Shareholders' equity [+]	7.4	12.5	16.9	2.5	-0.5	12.5	25.4	29.0
Paid-in capital	35.2	32.5	28.2	7.9	291.5	290.7	289.9	280.0
Retained earnings	-31.0	-21.6	-12.1	-5.5	-292.3	-278.5	-264.8	-251.2
Tangible shareholders' equity	-14.4	-9.5	-5.1	1.5	-0.5	12.5	25.4	29.0